Acne conglobata
ICD-10 L70.1 is a billable code used to indicate a diagnosis of acne conglobata.
Acne conglobata is a severe form of acne characterized by the presence of large, inflamed nodules and cysts that can coalesce to form abscesses. It primarily affects the face, back, and shoulders, where sebaceous glands are most active. The condition is often associated with significant scarring and can lead to psychological distress due to its appearance. The pathophysiology involves the obstruction of hair follicles, leading to the proliferation of Propionibacterium acnes and an inflammatory response. Disease progression can vary, with some patients experiencing intermittent flare-ups, while others may have persistent lesions. Diagnosis is primarily clinical, based on the characteristic appearance of the skin lesions, and may be supported by a patient history of acne vulgaris or family history of similar conditions. Differential diagnoses include hidradenitis suppurativa and other forms of severe acne. Treatment typically involves systemic therapies such as isotretinoin, antibiotics, and hormonal treatments, which require careful monitoring due to potential side effects.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
L70.1 specifically covers acne conglobata, which is characterized by the presence of painful, inflamed nodules and cysts, often leading to scarring. It is distinct from other forms of acne due to its severity and potential for systemic involvement.
L70.1 should be used when the clinical presentation includes severe nodular acne with significant inflammation and potential for scarring. It is important to differentiate it from L70.0 (Acne vulgaris) and L70.9 (Acne, unspecified) based on the severity and specific characteristics of the lesions.
Documentation should include a detailed clinical assessment of the skin lesions, treatment history, and any associated symptoms. Photographic evidence may also be beneficial, along with notes on the impact of the condition on the patient's quality of life.
